---
title: "Behind the Breakthrough: Strategic Insights from Sen-Jam's Executive Leadership and Destum Partners"
description: In March 2025, Sen-Jam Pharmaceutical hosted a pivotal webinar in collaboration with Destum Partners, a premier strategic advisory firm known for driving success in biotech partnerships, licensing, and M&A. This exclusive session offered investors and industry insiders a rare look behind the curtain—where scientific innovation meets commercial strategy. With several of our leading assets entering Phase 2 clinical milestones and patent protections expanding globally, the timing of this conversation could not have been more crucial. Together with Destum, we outlined our roadmap for unlocking value through co-development and licensing agreements, showcasing how our pipeline aligns with current market opportunities in public health, respiratory infection, addiction recovery, and next-gen anti-inflammatories.
---

<https://blog.sen-jam.com/stories>

# [Behind the Breakthrough: Strategic Insights from Sen-Jam's Executive Leadership and Destum Partners](https://blog.sen-jam.com/stories/executive-leadership-destum-partners)

 Written by [Sen-Jam](https://blog.sen-jam.com/stories/author/senjam) | Mar 27, 2025 6:00:00 PM

In March 2025, Sen-Jam Pharmaceutical hosted a pivotal webinar in collaboration with Destum Partners, a premier strategic advisory firm known for driving success in biotech partnerships, licensing, and M&A. This exclusive session offered investors and industry insiders a rare look behind the curtain—where scientific innovation meets commercial strategy. With several of our leading assets entering Phase 2 clinical milestones and patent protections expanding globally, the timing of this conversation could not have been more crucial. Together with Destum, we outlined our roadmap for unlocking value through co-development and licensing agreements, showcasing how our pipeline aligns with current market opportunities in public health, respiratory infection, addiction recovery, and next-gen anti-inflammatories.

Whether you’re a seasoned investor, a potential partner, or simply intrigued by the future of proactive medicine, this webinar delivers essential context on why Sen-Jam’s platform is poised to reshape the pharmaceutical landscape. It’s a chance to hear directly from our executive leadership—CEO Jim Iversen and Chief Clinical Officer Jackie Iversen—alongside the Destum team, as they unpack the differentiators behind our PAIR (Pleiotropic Anti-Inflammatory Regulators) technology and discuss the unique positioning of assets like SJP-001 and SJP-002C. Don’t miss this opportunity to better understand the momentum building behind Sen-Jam’s innovation engine and the value-creation strategies guiding our next phase of growth.

👉 Watch the full webinar here: [Sen-Jam x Destum Partners Strategic Update](https://vimeo.com/1070177528?fl=pl&fe=sh)

 

[View full post](https://blog.sen-jam.com/stories/executive-leadership-destum-partners)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Sen-Jam"
  },
  "dateModified" : "2026-02-16T23:12:12.132Z",
  "datePublished" : "2025-03-27T18:00:00Z",
  "headline" : "Behind the Breakthrough: Strategic Insights from Sen-Jam's Executive Leadership and Destum Partners",
  "image" : {
    "@type" : "ImageObject",
    "height" : 585,
    "url" : "https://48451917.fs1.hubspotusercontent-na1.net/hubfs/48451917/Screenshot%202026-02-16%20at%206.00.00%20PM.png",
    "width" : 1135
  },
  "mainEntityOfPage" : "https://blog.sen-jam.com/stories/executive-leadership-destum-partners",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60,
      "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
      "width" : 60
    },
    "name" : "Sen-Jam Pharmaceutical blog"
  }
}
```